Autonomix Medical, Inc. Common Stock

AMIXNASDAQHealthcare● Active

$0.40

$-0.01(-1.90%)

Market Cap$2069800

P/E Ratio—

52W High$2.64

52W Low$0.2

Avg Volume706K

Open$0.40

Beta-1.41

Free Cash Flow Financials Revenue

Autonomix Medical, Inc. Common Stock (AMIX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

AMIX · free cash flow · updated Jun 9, 2026

Core FCF metrics

AMIX · FCF · TTM · margin & CAGR

Free cash flow was −$12.3M for FY2026 (fiscal year ending 2026-03-31), down 48.6% year-over-year

FY2026 Free Cash Flow−$12.3M▼ -48.6% YoY

Trailing 12M (TTM)−$11.1Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

AMIX · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest−$12.3M(0M)−$12.3M▼ 48.6%—

FY2025−$8.3M(0M)−$8.3M▼ 24.1%—

FY2024−$6.6M(0M)−$6.7M▼ 259.5%—

FY2023−$1.9M(0M)−$1.9M▼ 378.8%—

FY2022−$387,307(0M)−$387,310——

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

AMIX · P/FCF · FCF yield · FCF per share

Autonomix Medical, Inc. Common Stock (AMIX) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-03-31

Cash flow statement summary

AMIX · cash flow statement · operating / investing / financing

For FY2026, Autonomix Medical, Inc. Common Stock generated −$12.3M in operating cash flow and spent 0M in capital expenditures, yielding −$12.3M in free cash flow.

Operating Activities

−$12.3M

Cash from core business operations

2026-03-31

Investing Activities

−$0.0M

CapEx, acquisitions & investments

2026-03-31

Financing Activities

+$10.2M

Buybacks, dividends & debt

2026-03-31

FCF FormulaOperating CF (−$12.3M) − |CapEx| (0M) = FCF (−$12.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

AMIX vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Autonomix Medical, Inc. Common StockYOU

AMIX

−$12.3M-48.6%—

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Autonomix Medical, Inc. Common Stock (AMIX) reported free cash flow of −$12.3M for FY2026 (fiscal year ending 2026-03-31), down 48.6% year-over-year.

Autonomix Medical, Inc. Common Stock has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 5 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

AMIX free cash flow · 8 questions

Autonomix Medical, Inc. Common Stock free cash flow was −$12.3M for FY2026, down 48.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$11.1M.

AMIX free cash flowAMIX FCFAMIX FCF 2026AMIX free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Autonomix Medical, Inc. Common Stock · Autonomix Medical, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026